雜志介紹

International Journal Of Pharmaceutics雜志介紹

《International Journal Of Pharmaceutics》是一本以English為主的未開放獲取國際優秀期刊，中文名稱國際藥劑學雜志，本刊主要出版、報道醫學-PHARMACOLOGY & PHARMACY領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為5.3，最新CiteScore 指數為10.7。

本刊近期中國學者發表的論文主要有：

• Corosolic acid-modified lipid nanoparticles as delivery carriers for DNA vaccines against avian influenza

  Author: Guo, Ziyan; Jing, Qiufang; Xu, Zhongyu; Zhang, Dahe; Zheng, Wenyun; Ren, Fuzheng

• Carrier-free Chinese herbal small molecules self-assembly with 3D-porous crystal framework as a synergistic anti-AD agent

  Author: Shen, Rui; Chen, Yuhong; Li, Xiangyu; Wang, Xi; Yang, Aihong; Kou, Xiaodi

• Rucaparib cocrystal: Improved solubility and bioavailability over camsylate

  Author: Xia, Mengyuan; Jiang, Yihua; Cheng, Yinxiang; Dai, Wenjuan; Rong, Xiaoyi; Zhu, Bingqing; Mei, Xuefeng

• Plasma metabolites-based design of long-acting peptides and their anticancer evaluation

  Author: Zhang, Chenyu; Li, Xiang; Xing, Zhenjian; Zhong, Honglan; Yu, Dianbao; Yu, Rui; Deng, Xin

英文介紹

International Journal Of Pharmaceutics雜志英文介紹

The International Journal of Pharmaceutics has an open access mirror journal International Journal of Pharmaceutics: X, sharing the same aims and scope, editorial team, submission system and rigorous peer review.

The International Journal of Pharmaceutics is the second most cited journal in the Pharmaceutical Sciences field out of 168 journals, being the true home for pharmaceutical scientists concerned with the physical, chemical and biological properties of devices and delivery systems for drugs, vaccines and biologicals, including their design, manufacture and evaluation. This includes evaluation of the properties of drugs, excipients such as surfactants and polymers and novel materials. The journal has special sections on pharmaceutical nanotechnology and personalized medicines, and publishes research papers, reviews, commentaries and letters to the editor as well as special issues.